Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
NCT00000444 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2011-02-11
Summary
This study will attempt to determine the best time to begin a smoking cessation program in individuals who undergo intensive treatment for alcohol dependence. The goal of this trial is to determine whether a smoking cessation program is more effective if it occurs at the same time as or after treatment for alcohol dependence. The study also will attempt to determine the effect of smoking cessation programs on the outcome of treatment for alcohol dependence.
Conditions
- Alcoholism
- Smoking
Interventions
- DRUG
-
nicotine replacement patch
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
collaborator NIH -
Minneapolis Veterans Affairs Medical Center
lead FED
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 21 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-09-30
- Primary Completion
- 2004-01-31
- Completion
- 2004-01-31
Countries
- United States
Study Locations
More Related Trials
-
Pharmacologic Relapse Prevention for Alcoholic Smokers
NCT00000457 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
NCT00342563 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
NCT01048944 ·Status: COMPLETED ·Phase: PHASE4
-
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
NCT02906644 ·Status: COMPLETED ·Phase: PHASE2
-
Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers
NCT02245308 ·Status: COMPLETED ·Phase: PHASE4
-
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
NCT00580645 ·Status: COMPLETED ·Phase: PHASE2
-
Innovative Interventions for Smoking Cessation
NCT01050569 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Nicotine Agents for Smoking Cessation
NCT00108537 ·Status: COMPLETED ·Phase: PHASE3
-
Varenicline in Drug Treatment
NCT01286584 ·Status: COMPLETED ·Phase: PHASE4
-
Individualizing Pharmacotherapy for African American Smokers
NCT03897439 ·Status: COMPLETED ·Phase: PHASE3
-
Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder
NCT02990455 ·Status: COMPLETED ·Phase: PHASE1
-
Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation
NCT02859142 ·Status: COMPLETED ·Phase: PHASE4
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
NCT02439944 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals
NCT00308763 ·Status: COMPLETED ·Phase: NA
-
Varenicline For Smokers In Recovery From Alcohol Dependence
NCT01092702 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence
NCT01208935 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
NCT00790569 ·Status: COMPLETED ·Phase: NA
-
Bupropion as a Smoking Cessation Aid in Alcoholics
NCT00044434 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence
NCT01011907 ·Status: COMPLETED ·Phase: NA
-
Treating Smokeless Tobacco Use in Rural Veterans
NCT02994082 ·Status: UNKNOWN ·Phase: NA
-
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
NCT02590393 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
NCT02825459 ·Status: COMPLETED ·Phase: NA
-
Adaptive Pharmacotherapy for Smoking Cessation
NCT02501265 ·Status: COMPLETED ·Phase: PHASE2